Stifel Maintains Hold on Treace Medical Concepts, Lowers Price Target to $6
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
Stifel analyst Rick Wise maintains Treace Medical Concepts (NASDAQ:TMCI) with a Hold and lowers the price target from $9 to $6.
Stifel analyst Rick Wise maintains Treace Medical Concepts (NASDAQ:TMCI) with a Hold and lowers the price target from $9 to $6.